comparemela.com

Latest Breaking News On - Pharmaceuticals stock down - Page 27 : comparemela.com

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $22 57 Average Price Target from Analysts

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the […]

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Consensus Recommendation of Buy from Analysts

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the […]

Titan Pharmaceuticals (NASDAQ:TTNP) Earns Sell Rating from Analysts at StockNews com

StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note published on Saturday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Down 2.8 % TTNP stock opened at $6.96 on Friday. Titan Pharmaceuticals has a 1 year low of $5.00 and a […]

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Short Interest Update

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 5,090,000 shares, a growth of 16.5% from the February 29th total of 4,370,000 shares. Based on an average daily trading volume, of 2,790,000 shares, the days-to-cover […]

SG Americas Securities LLC Sells 38,146 Shares of Xenon Pharmaceuticals Inc (NASDAQ:XENE)

SG Americas Securities LLC reduced its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 67.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,606 shares of the biopharmaceutical company’s stock after selling 38,146 shares during the quarter. SG […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.